DR. JOSHUA STERLING BROWN M.D. NPI 1083626519

NPI Details

DR. Joshua Sterling Brown, M.D. is an internal medicine in Santa Fe, NM with 27 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Joshua Sterling Brown, M.D. NPI is 1083626519. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Graduation Year:1998

The provider's business location address is:

1650 HOSPITAL DR
SUITE 200
SANTA FE, NM
ZIP 87505-769
Phone: (505) 982-4276
Fax: (505) 983-7571

The NPI 1083626519 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Test for allergy using allergenic extract (HCPCS:95004)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
• External counterpulsation, per treatment session (HCPCS:G0166)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Test to measure largest amount of air breathed in an out (HCPCS:94200)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Complete ultrasound study of arm and leg arteries (HCPCS:93923)
• Telephone medical discussion provided by nonphysician professional, 5-10 minutes (HCPCS:98966)
• Sleep study including heart rate, breathing, and sleep time (HCPCS:95800)
• Hemoglobin a1c level (HCPCS:83036)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Assessment of and care planning for impaired thought processing, typically 50 minutes (HCPCS:99483)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Urinalysis, manual test (HCPCS:81002)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Established patient home visit, typically 25 minutes (HCPCS:99348)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative (HCPCS:86328)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Telephone medical discussion provided by nonphysician professional, 11-20 minutes (HCPCS:98967)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)

The enumeration date for this NPI number is 8/13/2006 and was last updated on 3/26/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.